The Journal of Phytopharmacology, 2016;5(6):230-233 ; DOI:10.31254/phyto.2016.5604
Standardization of Vyoshadi Saktu a Pathykalpana (Nutritional supplement) in Diabetes
Arati Dubewa1 , Medha Kulkarni1 , Anupama Dashetwar2
1. Professor & HOD, Department of Rasashasta, Dr. D.Y. Patil College of Ayurved & Research Center, Pimpri, Pune, Maharashtra, India
2. Associate Professor, Dyanpith Shikshan Sanstha, Bhor, Pune, Maharashtra, India
*Author to whom correspondence should be addressed.
Neuropathy and Cardiac complications are the most common trouble in diabetes mellitus with progressive damage due to complex pathogenesis. Many conventional pharmacological agents were withdrawn from clinical studies either due to lack of efficacy or due to side effects on major organs. Over the period of time traditional herbal plants were utilized in the treatment & management of diabetic complications. The aim of the present research work was to investigate efficacy and dynamics of Operculina turpethum root (OT) in STZ induced diabetic neuropathy and cardiac complications. Chronic treatment of crude extract of OT (500 mg/kg) showed positive effect in diabetic animals with significant reduction in blood glucose level, serum nitrite, brain homogenate nitrite & nerve homogenate nitrite levels as compared to diabetic control animals. Treatment with OT showed significant rise in body weight compared to Control animals & polyphagia were observed in diabetic animals persisted throughout the period of 8 weeks. Significant improvement was observed by treatment with OT in behavioural parameters like tail flick latency reduction and rise in pain threshold capacity. Nerve conduction velocity measured through BIOPAC system showed significant (P
Vyoshadi Saktu, diabetes, Standardization.
HOW TO CITE THIS ARTICLE
Dubewa A, Kulkarni M, Dashetwar A. Standardization of Vyoshadi Saktu a Pathykalpana (Nutritional supplement) in Diabetes. J Phytopharmacol 2016;5(6):220-224.
Creative Commons (CC) License-
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY 4.0) license. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. (http://creativecommons.org/licenses/by/4.0/).
Copyright
Copyright © 2016 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0.